Clinical Trial Update: Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV [Phase 2]

View source ↗

Summary

This report notes the completion of a Phase 2 clinical trial evaluating a therapeutic HIV vaccine in combination with interleukin-2 to boost HIV-specific immune…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Therapeutic HIV vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED